BioRealm has been selected by NVIDIA to be part of their Inception Program, designed to nurture "dedicated and exceptional startups who are revolutionizing industries with advances in AI and data science."
NVIDIA marketed the world's first Graphical Processing Unit (GPU) in 1999, and today are the world's largest manufacturer and developer of GPUs. NVIDIA GPUs have become an essential tool for those working in virtual reality, high performance computing, and artificial intelligence.
We are extremely honored to have been selected by NVIDIA and to receive such recognition by an industry giant that has played an extraordinary role in the renaissance of artificial intelligence.
NVIDIA's generous support will allow us to provide even more value to our clients, and we are excited to see what we can all create together.
In this interview with Carolyn Ervin, biostatistician, and co-founder of BioRealm, we discuss how to get the most value from experienced biostatisticians, developments in the industry and her associated concerns, a few of her favorite tools when working on clinical trials, and project management secrets.
Estimated reading time: 4 minutes, 51 seconds
In this interview with James Baurley, data scientist, and co-founder of BioRealm, LLC., we discuss how biological markers, especially genetic biological markers, may be used in clinical trials, and a few of the computational and statistical issues and limitations.
Estimated reading time: 4 minutes, 43 seconds